The 64 rating InvestorsObserver gives to Krystal Biotech Inc (KRYS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 89 percent of stocks in the Biotechnology industry, KRYS’s 64 overall rating means the stock scores better than 64 percent of all stocks.
Click Here to get the full Stock Score Report on Krystal Biotech Inc (KRYS) Stock.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Krystal Biotech Inc Stock Today?
Krystal Biotech Inc (KRYS) stock has fallen -1.62% while the S&P 500 is higher by 0.05% as of 9:56 AM on Thursday, Nov 14. KRYS is lower by -$0.83 from the previous closing price of $51.34 on volume of 1,982 shares. Over the past year the S&P 500 is higher by 14.58% while KRYS is higher by 132.66%. KRYS lost -$1.17 per share the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Krystal Biotech Inc click here.
